{
"info": {
"nct_id": "NCT04965220",
"official_title": "A Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors",
"inclusion_criteria": "* 18Y≤Age≤75Y\n* Good Organ Function\n* Expected survival time ≥ 3 months\n* Metastatic/recurrent advanced BRAF+ solid tumors that have been diagnosed histologically and have failed standard treatment\n* Previous failure to standard treatment, intolerance to standard treatment, absence of standard treatment, or insuitability for standard treatment at this stage.\n* ECOG score 0-1;\n* Expected survival time of more than 3 months;\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Previous treatment with BRAF inhibitors or MEK inhibitors\n* Symptomatic brain or meningeal metastases (unless the patient has been on > treatment for 6 months, has no evidence of progress on imaging within 4 weeks prior to initial administration, and tumor-related clinical symptoms are stable).\n* Current or former patients with interstitial lung disease;\n* Active clinical severe infection;\n* A history of other malignancies within two years, except for cured carcinoma in situ of the cervix or basal cell carcinoma of the skin.\n* Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy), may be given during the study period.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* 18Y≤Age≤75Y",
"criterions": [
{
"exact_snippets": "18Y≤Age≤75Y",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "Y"
},
{
"operator": "<=",
"value": 75,
"unit": "Y"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "18Y≤Age≤75Y",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "Y"
},
{
"operator": "<=",
"value": 75,
"unit": "Y"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Good Organ Function",
"criterions": [
{
"exact_snippets": "Good Organ Function",
"criterion": "organ function",
"requirement": {
"requirement_type": "quality",
"expected_value": "good"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Good Organ Function",
"criterion": "organ function",
"requirement": {
"requirement_type": "quality",
"expected_value": "good"
}
}
]
}
},
{
"identified_line": {
"line": "* Expected survival time ≥ 3 months",
"criterions": [
{
"exact_snippets": "Expected survival time ≥ 3 months",
"criterion": "expected survival time",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Expected survival time ≥ 3 months",
"criterion": "expected survival time",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Metastatic/recurrent advanced BRAF+ solid tumors that have been diagnosed histologically and have failed standard treatment",
"criterions": [
{
"exact_snippets": "Metastatic/recurrent advanced BRAF+ solid tumors",
"criterion": "BRAF+ solid tumors",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"metastatic",
"recurrent",
"advanced"
]
}
},
{
"exact_snippets": "diagnosed histologically",
"criterion": "diagnosis method",
"requirement": {
"requirement_type": "method",
"expected_value": "histologically"
}
},
{
"exact_snippets": "failed standard treatment",
"criterion": "treatment response",
"requirement": {
"requirement_type": "response",
"expected_value": "failed"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Metastatic/recurrent advanced BRAF+ solid tumors",
"criterion": "BRAF+ solid tumors",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"metastatic",
"recurrent",
"advanced"
]
}
},
{
"exact_snippets": "diagnosed histologically",
"criterion": "diagnosis method",
"requirement": {
"requirement_type": "method",
"expected_value": "histologically"
}
}
]
},
{
"exact_snippets": "failed standard treatment",
"criterion": "treatment response",
"requirement": {
"requirement_type": "response",
"expected_value": "failed"
}
}
]
}
},
{
"identified_line": {
"line": "* Previous failure to standard treatment, intolerance to standard treatment, absence of standard treatment, or insuitability for standard treatment at this stage.",
"criterions": [
{
"exact_snippets": "Previous failure to standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "response",
"expected_value": "failure"
}
},
{
"exact_snippets": "intolerance to standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "tolerance",
"expected_value": false
}
},
{
"exact_snippets": "absence of standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "insuitability for standard treatment at this stage",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "suitability",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Previous failure to standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "response",
"expected_value": "failure"
}
},
{
"exact_snippets": "intolerance to standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "tolerance",
"expected_value": false
}
},
{
"exact_snippets": "absence of standard treatment",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "insuitability for standard treatment at this stage",
"criterion": "standard treatment",
"requirement": {
"requirement_type": "suitability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* ECOG score 0-1;",
"criterions": [
{
"exact_snippets": "ECOG score 0-1",
"criterion": "ECOG score",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG score 0-1",
"criterion": "ECOG score",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Expected survival time of more than 3 months;",
"criterions": [
{
"exact_snippets": "Expected survival time of more than 3 months",
"criterion": "survival time",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Expected survival time of more than 3 months",
"criterion": "survival time",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Previous treatment with BRAF inhibitors or MEK inhibitors",
"criterions": [
{
"exact_snippets": "Previous treatment with BRAF inhibitors",
"criterion": "BRAF inhibitor treatment",
"requirement": {
"requirement_type": "previous treatment",
"expected_value": true
}
},
{
"exact_snippets": "Previous treatment with ... MEK inhibitors",
"criterion": "MEK inhibitor treatment",
"requirement": {
"requirement_type": "previous treatment",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Previous treatment with BRAF inhibitors",
"criterion": "BRAF inhibitor treatment",
"requirement": {
"requirement_type": "previous treatment",
"expected_value": true
}
},
{
"exact_snippets": "Previous treatment with ... MEK inhibitors",
"criterion": "MEK inhibitor treatment",
"requirement": {
"requirement_type": "previous treatment",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Symptomatic brain or meningeal metastases (unless the patient has been on > treatment for 6 months, has no evidence of progress on imaging within 4 weeks prior to initial administration, and tumor-related clinical symptoms are stable).",
"criterions": [
{
"exact_snippets": "Symptomatic brain or meningeal metastases",
"criterion": "brain or meningeal metastases",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
},
{
"exact_snippets": "unless the patient has been on > treatment for 6 months",
"criterion": "treatment duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "months"
}
}
},
{
"exact_snippets": "no evidence of progress on imaging within 4 weeks prior to initial administration",
"criterion": "progress on imaging",
"requirement": {
"requirement_type": "evidence of progress",
"expected_value": false
}
},
{
"exact_snippets": "tumor-related clinical symptoms are stable",
"criterion": "tumor-related clinical symptoms",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable"
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Symptomatic brain or meningeal metastases",
"criterion": "brain or meningeal metastases",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
},
"then_criteria": {
"not_criteria": {
"and_criteria": [
{
"exact_snippets": "unless the patient has been on > treatment for 6 months",
"criterion": "treatment duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "months"
}
}
},
{
"exact_snippets": "no evidence of progress on imaging within 4 weeks prior to initial administration",
"criterion": "progress on imaging",
"requirement": {
"requirement_type": "evidence of progress",
"expected_value": false
}
},
{
"exact_snippets": "tumor-related clinical symptoms are stable",
"criterion": "tumor-related clinical symptoms",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable"
}
}
]
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Current or former patients with interstitial lung disease;",
"criterions": [
{
"exact_snippets": "Current or former patients with interstitial lung disease",
"criterion": "interstitial lung disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Current or former patients with interstitial lung disease",
"criterion": "interstitial lung disease",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Active clinical severe infection;",
"criterions": [
{
"exact_snippets": "Active clinical severe infection",
"criterion": "infection",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "Active clinical severe infection",
"criterion": "infection",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Active clinical severe infection",
"criterion": "infection",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "Active clinical severe infection",
"criterion": "infection",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
}
]
}
},
{
"identified_line": {
"line": "* A history of other malignancies within two years, except for cured carcinoma in situ of the cervix or basal cell carcinoma of the skin.",
"criterions": [
{
"exact_snippets": "A history of other malignancies within two years",
"criterion": "history of other malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2,
"unit": "years"
}
]
}
}
},
{
"exact_snippets": "except for cured carcinoma in situ of the cervix",
"criterion": "cured carcinoma in situ of the cervix",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
},
{
"exact_snippets": "except for ... basal cell carcinoma of the skin",
"criterion": "basal cell carcinoma of the skin",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "A history of other malignancies within two years",
"criterion": "history of other malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2,
"unit": "years"
}
]
}
}
},
{
"not_criteria": {
"exact_snippets": "except for cured carcinoma in situ of the cervix",
"criterion": "cured carcinoma in situ of the cervix",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
},
{
"not_criteria": {
"exact_snippets": "except for ... basal cell carcinoma of the skin",
"criterion": "basal cell carcinoma of the skin",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
}
]
}
]
},
"then_criteria": null,
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy), may be given during the study period.",
"criterions": [
{
"exact_snippets": "Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy)",
"criterion": "anti-tumor treatments",
"requirement": {
"requirement_type": "types",
"expected_value": [
"chemotherapy",
"targeted therapy",
"radiation therapy"
]
}
},
{
"exact_snippets": "Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy)",
"criterion": "anti-tumor treatments",
"requirement": {
"requirement_type": "exclusion",
"expected_value": "palliative radiation therapy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy)",
"criterion": "anti-tumor treatments",
"requirement": {
"requirement_type": "types",
"expected_value": [
"chemotherapy",
"targeted therapy",
"radiation therapy"
]
}
},
{
"not_criteria": {
"exact_snippets": "Other anti-tumor treatments, such as chemotherapy, targeted therapy, or radiation therapy (except palliative radiation therapy)",
"criterion": "anti-tumor treatments",
"requirement": {
"requirement_type": "exclusion",
"expected_value": "palliative radiation therapy"
}
}
}
]
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}